AC Immune News

AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

May 21 07:04

AC Immune | 144: Notice of proposed sale of securities pursuant to Rule 144

May 16 13:26

AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

May 13 05:18

AC Immune | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 13 05:04

AC Immune | F-3: Registration statement for specified transactions by certain foreign private issuers

Mar 14 15:46

AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 06:48

AC Immune | 20-F: Registration statement / Annual report / Transition report

Mar 14 06:34

AC Immune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affiris AG in Liqu(6.66%)

Feb 9 15:37

AC Immune | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 21 23:00

AC Immune | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 2 23:00

AC Immune | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 27, 2023 23:00

AC Immune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(14.8%),BVF Inc.(14.8%), etc.

Dec 19, 2023 15:53

AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 19, 2023 07:53

AC Immune | 424B5: Prospectus

Dec 15, 2023 16:27

AC Immune | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 15, 2023 15:31

AC Immune | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 15, 2023 06:27

AC Immune | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11, 2023 15:18

AC Immune | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 6, 2023 15:37

AC Immune | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 1, 2023 06:13

AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 3, 2023 06:30